A news story on WBBH out of Florida deals with the blood clot risk for Beyaz and other birth control pills containing the compound drospirenone.
Contraceptives with drospirenone include Yasmin, Yaz and Ocella.
The report features ...
continue reading...
According to the National Institute of Mental Health, depressive disorder can take several different forms.
The Institute makes a distinction between a short-lived feeling of sadness that lasts several days, and a long-term condition that interferes with daily life.
The condition is treatable. The Institute cites medication and psychotherapy as effective treatments.
But recent research suggests that some treatments may come with harmful side effects. A number of studies indicate antidepressants classified as ...
continue reading...
In a column in the Chicago Tribune, Joan Bengtson, M.D., gives advice on dealing with menopausal hot flashes when a risk of blood clots is present.
The woman seeking advice was diagnosed with a blood clot in her leg while using a hormone patch. Bengston writes that estrogen is the most effective prescription medicine for relieving hot flashes, but many women can’t take estrogen because of side effects including the formation ...
continue reading...In a piece for the Huffington Post, Harvard-trained psychiatrist Dr. Peter Breggin argues that antidepressants classified as selective serotonin reuptake inhibitors do more harm than good.
Breggin refers to considerable evidence that the antidepressants worsen depression and cause severe behavioral abnormalities, attributing the problem to “compensatory changes” in neurotransmitters as the brain resists the drug effect.
“It has been apparent for many years that chronic exposure to SSRI antidepressants frequently makes people feel apathetic or less engaged in their lives, and ultimately ...
continue reading...
According to the federal Centers for Disease Control and Prevention, diagnosing and treating clinical depression in women is a vital part of reproductive health.
Depression is treatable. But several studies have linked the class of antidepressants known as selective serotonin reuptake inhibitors, or SSRIs, with potentially dangerous heart and lung defects in babies born to women who take the drugs while pregnant. SSRI antidepressants include Prozac and Zoloft.
A ...
continue reading...
In a recent piece in Forbes, former president of Pfizer research and development John LaMattina discusses the limitations of the popular antidepressants classified as selective serotonin reuptake inhibitors, or SSRIs.
LaMattina mentions an antidepressant that pharmaceutical company Lundbeck is developing, called Lu AA21004. He writes that researchers are hoping the new medication won’t have some of the drawbacks of SSRIs, which include Prozac and Zoloft.
Those drawbacks, according to LaMattina, include a ...
continue reading...
